埃夫特(688165.SH):上半年公司機器人整機銷量同比增長約29%
格隆匯10月14日丨埃夫特(688165.SH)投資者關係活動記錄表顯示,2024年上半年,公司機器人整機銷量同比增長約29%,埃夫特上半年出貨量的增量主要來自於電子製造和通用工業,光伏、鋰電同比下滑較大。公司焊接、噴塗、碼垛等跨行業應用也取得顯著突破,弧焊應用同比增長超100%,其中智能焊接業務出貨台數同比增長近150%,噴塗機器人出貨同比增長超45%,碼垛機器人出貨台數同比增長約260%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.